Abarceo Pharma AB Company
Abarceo Pharma is a spin out of Lund University Diabetes Center and is located in Malmo Sweden. Scientific founders Prof. Claes Wollheim, MD and Associate Prof. Albert Salehi are world-class experts in beta cell biology. Abarceo Pharma is a Lund University Holding company and was founded in December 2017. The company is dedicated to developing novel therapeutics for type-2 diabetes based upon a deep molecular and genetic understanding of the disease.
Industry:
Geroscience
Headquarters:
Malmö, Skane Lan, Sweden
Zip:
1-10
Founded Date:
2017-01-01
Employees Number:
1-10
Acquisitions Number:
1
Investors Number:
2552616
Total Funding:
2552616
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership